glucagon has been researched along with Hyperlipoproteinemia Type II in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jover, E; Rodriguez, F; Velasco, R | 1 |
Agosti, C; Morenghi, R; Saponati, G; Uccella, R | 1 |
Descovich, G; Fragiacomo, C; Gatti, E; Noseda, G; Sirtori, CR | 1 |
Farriaux, JP; Luyckx, AS; Ribet, M | 1 |
Andĕl, M; Brodan, V; Brodanová, M; Kucerová, L | 1 |
Andĕl, M; Brodan, V; Grafnetter, D; Kucerová, L; Kuhn, E; Veselková, A | 1 |
6 other study(ies) available for glucagon and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Glucagon and primary hyperlipidemias.
Topics: Glucagon; Growth Hormone; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypoglycemia; Insulin | 1983 |
Possible glucagon-mediated hypocholesterolemic activity of a nicotinic acid derivative (sorbinicate).
Topics: Adult; Cholesterol; Glucagon; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Nicotinic Acids; Obesity; Sorbitol; Triglycerides | 1983 |
Glucagon release following experimental diets in man: effects of soybean and casein enriched diets.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Caseins; Cholesterol; Dietary Proteins; Glucagon; Glycine max; Humans; Hyperlipoproteinemia Type II; Insulin; Middle Aged; Time Factors; Triglycerides | 1982 |
Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt.
Topics: Adult; Child; Follow-Up Studies; Glucagon; Glucose; Humans; Hyperlipoproteinemia Type II; Insulin; Male; Portacaval Shunt, Surgical | 1980 |
The effect of I.V. glucagon administration on selected metabolic parameters in patients with type IIa, IIb and IV primary hyperlipoproteinaemia.
Topics: Adult; Female; Glucagon; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Infusions, Parenteral; Male; Middle Aged | 1980 |
[Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
Topics: Adult; Cholesterol; Female; Glucagon; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Infusions, Parenteral; Male; Middle Aged; Triglycerides | 1980 |